MedPath

Seoul National University Hospital

Seoul National University Hospital logo
🇰🇷South Korea
Ownership
Private
Established
2003-01-01
Employees
501
Market Cap
-
Website
https://www.snubh.org

Evaluate the Effects of the Environmental Change in Intestine by Antibiotics on the Pharmacokinetic Characteristics of Simvastatin in Healthy Male Volunteers

Phase 1
Completed
Conditions
Simvastatin Pharmacokinetics and Gut Microbiome
Interventions
First Posted Date
2018-01-19
Last Posted Date
2018-01-19
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
6
Registration Number
NCT03403972
Locations
🇰🇷

Seoul National University Hospital Clinical Trial Center, Seoul, Korea, Republic of

The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic Cancer

Phase 4
Conditions
Pancreatic Adenocarcinoma
Chemotherapy Effect
Interventions
Drug: Chemotherapy (Gemcitabine + nab-paclitaxel)
First Posted Date
2018-01-17
Last Posted Date
2018-02-12
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
40
Registration Number
NCT03401827
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

Treatment for Eye Bag Using Micro-insulated Needle Device

Not Applicable
Completed
Conditions
Sagging Eyelid Skin
Interventions
Device: Study population
First Posted Date
2018-01-12
Last Posted Date
2018-01-17
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
24
Registration Number
NCT03397758

ID-JPL934 for Abnormal Bowel Movement

Not Applicable
Conditions
Abnormal Bowel Movement Such as Constipation, Diarrhea, Abdominal Pain
Interventions
Dietary Supplement: ID-JPL934
Dietary Supplement: Placebo
First Posted Date
2018-01-10
Last Posted Date
2018-01-30
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
112
Registration Number
NCT03395626
Locations
🇰🇷

Seoul National University Bungdang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of

Comparison of Change of Tissue Oxygenation During a Vascular Occlusion Test Using Two Different NIRS (O3TM vs. INVOS®)

Not Applicable
Completed
Conditions
Tissue Oxygen Saturation
Interventions
Device: O3
First Posted Date
2018-01-10
Last Posted Date
2019-07-09
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
20
Registration Number
NCT03395834
Locations
🇰🇷

SNUH, Seoul, Jongro Gu, Korea, Republic of

🇰🇷

Hee-Soo Kim, Seoul, Soul-t'ukpyolsi, Korea, Republic of

🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

Effect of Leg Elevation on Prevention of Intraoperative Hypotension During Beach Chair Position

Not Applicable
Completed
Conditions
Shoulder Disease
Intraoperative Hypotension
Cerebral Ischemia
Interventions
Procedure: leg elevation
First Posted Date
2018-01-08
Last Posted Date
2019-12-27
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
50
Registration Number
NCT03393559
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

Comparing Postoperative Pain Following COX-2 and Prostanoids Expression

Not Applicable
Conditions
Female Genital Disease
Interventions
Drug: COX-2 inhibitor
Drug: Placebo Oral Tablet
Procedure: Preoperative peritoneal biopsy
Procedure: Single-port laparoscopic surgery
Procedure: Postoperative peritoneal biopsy
First Posted Date
2018-01-05
Last Posted Date
2018-01-05
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
60
Registration Number
NCT03391570
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

Usefulness of Cardiovascular Disease (CVD) Management Solution

Not Applicable
Conditions
Cardiovascular Diseases
Interventions
Behavioral: Smartphone app
First Posted Date
2018-01-05
Last Posted Date
2018-03-26
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
666
Registration Number
NCT03392259
Locations
🇰🇷

Seoul National University Bundang Hospital, Seongnam, Korea, Republic of

Evaluation of Optimal Ablation Index for Pulmonary Vein Isolation in Patients With AF Prospective Registry

Conditions
Atrial Fibrillation
First Posted Date
2018-01-03
Last Posted Date
2020-03-18
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
70
Registration Number
NCT03389074
Locations
🇰🇷

Seoul National university Hostpital, Seoul, Korea, Republic of

Phase II Study of Avelumab in Patients With Advanced Hepatocellular Carcinoma After Prior Sorafenib Treatment

Phase 2
Completed
Conditions
Carcinoma, Hepatocellular
Interventions
First Posted Date
2018-01-03
Last Posted Date
2021-03-17
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
30
Registration Number
NCT03389126
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath